ZNZ Pharma

ZNZ Pharma 2 is a pharmaceutical platform company established by the global private equity firm Advent International to consolidate and scale businesses in the specialty active pharmaceutical ingredient (API) and contract development and manufacturing organization (CDMO) sectors. The company serves as a strategic holding entity for major assets including Cohance Lifesciences and Suven Pharmaceuticals, providing end-to-end services from drug discovery and development to full-scale commercial manufacturing. ZNZ Pharma 2 focuses on high-value, complex chemistries and maintains a significant operational footprint in India, serving a global clientele of pharmaceutical and biotech companies. Through its integrated subsidiaries, the platform targets high-growth therapeutic areas such as the central nervous system, oncology, and ophthalmology.